Recruitment and patient involvement
The principal investigator at each site will be responsible for the enrolment of patients. Patients will be screened at 16 centers across Australia, the Czech Republic, Germany, the Netherlands, Slovakia, Switzerland, the UK, and the USA. The list of study sites is available via 